Soluble recombinant α

Soluble recombinant α

V3 V3 V3 The invention relates to a novel purified recombinant αβadhesion receptor which shows an unimpaired ligand binding activity, and a process for preparing said soluble non-membrane bound receptor in excellent yields by recombinant techniques using a baculovirus-insect cell expression system....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Goodman, Simon L, Diefenbach, Beate, Güssow, Detelv, Mehta, Raj, Cullen, Eilish, Brown, Alex
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Goodman, Simon L
Diefenbach, Beate
Güssow, Detelv
Mehta, Raj
Cullen, Eilish
Brown, Alex
description V3 V3 V3 The invention relates to a novel purified recombinant αβadhesion receptor which shows an unimpaired ligand binding activity, and a process for preparing said soluble non-membrane bound receptor in excellent yields by recombinant techniques using a baculovirus-insect cell expression system. The so-synthesized soluble receptor may be used very easily as screening tool for new therapeutic compounds which may inhibit the natural αβadhesion receptor. Such therapeutic compounds which can be discovered very easily, fast and without health risk by means of the soluble receptors according to the invention may be, for example, RGD peptides or non-peptidic compounds mimicking the natural ligand epitopes. The invention relates, furthermore, to a corresponding process for preparing recombinant full-length αβadhesion receptor in excellent yields, additionally using detergents to dissolve the membrane bound receptor from the surface of the host cell.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08067197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08067197</sourcerecordid><originalsourceid>FETCH-uspatents_grants_080671973</originalsourceid><addsrcrecordid>eNrjZBALzs8pTcpJVShKTc7PTcrMS8wrUTi3kYeBNS0xpziVF0pzMyi4uYY4e-iWFhcklqTmlRTHpxclgigDCwMzc0NLc2MilAAAxNkjHg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Soluble recombinant α</title><source>USPTO Issued Patents</source><creator>Goodman, Simon L ; Diefenbach, Beate ; Güssow, Detelv ; Mehta, Raj ; Cullen, Eilish ; Brown, Alex</creator><creatorcontrib>Goodman, Simon L ; Diefenbach, Beate ; Güssow, Detelv ; Mehta, Raj ; Cullen, Eilish ; Brown, Alex ; Merck Patent GmbH</creatorcontrib><description>V3 V3 V3 The invention relates to a novel purified recombinant αβadhesion receptor which shows an unimpaired ligand binding activity, and a process for preparing said soluble non-membrane bound receptor in excellent yields by recombinant techniques using a baculovirus-insect cell expression system. The so-synthesized soluble receptor may be used very easily as screening tool for new therapeutic compounds which may inhibit the natural αβadhesion receptor. Such therapeutic compounds which can be discovered very easily, fast and without health risk by means of the soluble receptors according to the invention may be, for example, RGD peptides or non-peptidic compounds mimicking the natural ligand epitopes. The invention relates, furthermore, to a corresponding process for preparing recombinant full-length αβadhesion receptor in excellent yields, additionally using detergents to dissolve the membrane bound receptor from the surface of the host cell.</description><language>eng</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8067197$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64028</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8067197$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Goodman, Simon L</creatorcontrib><creatorcontrib>Diefenbach, Beate</creatorcontrib><creatorcontrib>Güssow, Detelv</creatorcontrib><creatorcontrib>Mehta, Raj</creatorcontrib><creatorcontrib>Cullen, Eilish</creatorcontrib><creatorcontrib>Brown, Alex</creatorcontrib><creatorcontrib>Merck Patent GmbH</creatorcontrib><title>Soluble recombinant α</title><description>V3 V3 V3 The invention relates to a novel purified recombinant αβadhesion receptor which shows an unimpaired ligand binding activity, and a process for preparing said soluble non-membrane bound receptor in excellent yields by recombinant techniques using a baculovirus-insect cell expression system. The so-synthesized soluble receptor may be used very easily as screening tool for new therapeutic compounds which may inhibit the natural αβadhesion receptor. Such therapeutic compounds which can be discovered very easily, fast and without health risk by means of the soluble receptors according to the invention may be, for example, RGD peptides or non-peptidic compounds mimicking the natural ligand epitopes. The invention relates, furthermore, to a corresponding process for preparing recombinant full-length αβadhesion receptor in excellent yields, additionally using detergents to dissolve the membrane bound receptor from the surface of the host cell.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZBALzs8pTcpJVShKTc7PTcrMS8wrUTi3kYeBNS0xpziVF0pzMyi4uYY4e-iWFhcklqTmlRTHpxclgigDCwMzc0NLc2MilAAAxNkjHg</recordid><startdate>20111129</startdate><enddate>20111129</enddate><creator>Goodman, Simon L</creator><creator>Diefenbach, Beate</creator><creator>Güssow, Detelv</creator><creator>Mehta, Raj</creator><creator>Cullen, Eilish</creator><creator>Brown, Alex</creator><scope>EFH</scope></search><sort><creationdate>20111129</creationdate><title>Soluble recombinant α</title><author>Goodman, Simon L ; Diefenbach, Beate ; Güssow, Detelv ; Mehta, Raj ; Cullen, Eilish ; Brown, Alex</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_080671973</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Goodman, Simon L</creatorcontrib><creatorcontrib>Diefenbach, Beate</creatorcontrib><creatorcontrib>Güssow, Detelv</creatorcontrib><creatorcontrib>Mehta, Raj</creatorcontrib><creatorcontrib>Cullen, Eilish</creatorcontrib><creatorcontrib>Brown, Alex</creatorcontrib><creatorcontrib>Merck Patent GmbH</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Goodman, Simon L</au><au>Diefenbach, Beate</au><au>Güssow, Detelv</au><au>Mehta, Raj</au><au>Cullen, Eilish</au><au>Brown, Alex</au><aucorp>Merck Patent GmbH</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Soluble recombinant α</title><date>2011-11-29</date><risdate>2011</risdate><abstract>V3 V3 V3 The invention relates to a novel purified recombinant αβadhesion receptor which shows an unimpaired ligand binding activity, and a process for preparing said soluble non-membrane bound receptor in excellent yields by recombinant techniques using a baculovirus-insect cell expression system. The so-synthesized soluble receptor may be used very easily as screening tool for new therapeutic compounds which may inhibit the natural αβadhesion receptor. Such therapeutic compounds which can be discovered very easily, fast and without health risk by means of the soluble receptors according to the invention may be, for example, RGD peptides or non-peptidic compounds mimicking the natural ligand epitopes. The invention relates, furthermore, to a corresponding process for preparing recombinant full-length αβadhesion receptor in excellent yields, additionally using detergents to dissolve the membrane bound receptor from the surface of the host cell.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_08067197
source USPTO Issued Patents
title Soluble recombinant α
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T20%3A03%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Goodman,%20Simon%20L&rft.aucorp=Merck%20Patent%20GmbH&rft.date=2011-11-29&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08067197%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true